Equibles does not estimate personal net worth.
Get an email with a short summary when Northrop Grumman Corp publishes a filing, an earnings call transcript or a press release.
Get NOC alertsJohn Green is recorded as CFO at Northrop Grumman Corp (NOC) and CFO at Cogent Biosciences, Inc. (COGT). The newest filing on record that lists John Green as CFO at Cogent Biosciences, Inc. (COGT) is dated April 23, 2026. The proxy statement of Cogent Biosciences, Inc. reports total compensation of $8,546,329 for John Green in fiscal 2025, including a base salary of $510,677. Disclosed compensation is on record for 3 fiscal years. John Green has spoken on 4 earnings calls across 1 company, most recently for Northrop Grumman Corp on October 20, 2026. Northrop Grumman Corp is classified in the Aerospace & Defense industry within the Industrials sector. Cogent Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Northrop Grumman Corp includes David F. Keffer (CFO), John Greene (CFO), Kenneth B. Crews (CFO) and 7 others.
“I'll start with our third quarter financial results as shown on slide four. Momentum continues to build throughout our portfolio. As Kathy shared, backlog increased 20% to $110 billion compared to the third quarter of last year, driven by bookings of over $16 billion.”
“They constitute forward-looking statements under the safe harbor provisions of federal securities laws.”
“I'll start with our first quarter segment results on slide four. We continue to experience robust demands for our products and capabilities. Awards totaled $9.8 billion in Q1, and we ended the period with $96 billion in backlog.”
“It's an exciting time to join Norfolk Grumman as we enter 2026 with strong momentum across our portfolio. I'll begin on slide eight by walking you through our guidance for 2026, including expectations for a year of broad-based growth across the portfolio.”
Proxy statement
Start not stated–present
Last confirmed April 17, 2026
Start not stated–present
Last confirmed April 23, 2026
Proxy statement
Start not stated–2020-04-29
Last confirmed by a filing; no departure on record
Aerospace & Defense · Industrials
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cogent Biosciences, Inc. (COGT) | Chief Financial Officer | $510,677 | $8,546,329 |
| 2024 | Cogent Biosciences, Inc. (COGT) | Chief Financial Officer | $490,025 | $1,747,767 |
| 2020 | Cogent Biosciences, Inc. (COGT) | Chief Financial Officer | $323,957 | $2,139,245 |
